Hand Eczema Clinical Trial
Official title:
Satisfaction Survey - Cicaplast Mains
The participants presenting with hand problems and meeting the inclusion criteria are asked to apply the study product for one month. They are evaluated before and after treatment.
The international, open, observational survey is conducted in 3 different countries. Regarding the statistical analysis, the global satisfaction is described in 5 classes and in 2 classes "Satisfied + Very satisfied" vs. "Neither satisfied nor dissatisfied + Not so satisfied + Not at all satisfied". The 95% Confidence Interval (CI) of the percent of "Satisfied + Very satisfied" is also given. On patients who already used cream at the inclusion, the following analyses are performed: - Cross-tabulation between both visits, - Test of the evolution between both visits using a special procedure for ordinal data with repeated measures, - Description of a summary variable in 3 classes (Improved / No change / Worsened). For the analysis of the hands problems, each sign is described at the inclusion and at the evaluation visit. The difference Evaluation-Inclusion is also given. The evolution of the sign is performed by a Wilcoxon test for matched samples. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00576550 -
A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema
|
Phase 4 | |
Completed |
NCT00404196 -
LEO19123 Cream in the Treatment of Hand Eczema
|
Phase 2 | |
Completed |
NCT05763914 -
A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners
|
N/A | |
Recruiting |
NCT03026946 -
Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
|
Phase 3 | |
Recruiting |
NCT03026907 -
Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema
|
Phase 3 | |
Completed |
NCT00488241 -
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema
|
Phase 4 | |
Active, not recruiting |
NCT05906628 -
Topical Ruxolitinib Evaluation in Chronic Hand Eczema
|
Phase 2 | |
Terminated |
NCT01826630 -
A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema
|
N/A | |
Recruiting |
NCT04449575 -
Hand Eczema in the Health Care Sector
|
||
Withdrawn |
NCT05219864 -
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
|
Phase 3 | |
Completed |
NCT01591785 -
Treatment of Staphylococcus Aureus Colonization in Hand Eczema
|
N/A | |
Completed |
NCT00826592 -
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
|
N/A | |
Completed |
NCT02664805 -
Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema
|
Phase 2 | |
Active, not recruiting |
NCT04512339 -
Dupilumab in Severe Chronic Hand Eczema
|
Phase 2 | |
Completed |
NCT04375410 -
Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic
|